The global malaria diagnostic market is projected to grow at a CAGR of 4.01% over the forecast period of 2017-2023. High quality malaria diagnostic kits are important as any misdiagnosis or delay in treatment can result in significant morbidity and mortality. Malaria diagnostics provide early and accurate diagnosis of the disease which is essential for the rapid and effective disease management. As per report by WHO, in 2016, there were an estimated 216 million cases of malaria, an increase of about 5 million cases over 2015. Molecular diagnostics, rapid diagnostic tests (RDTs) are the examples of malaria diagnostic techniques that are frequently used. The growth in the market may be attributed to the advancements in the technology for the rapid detection of the disease. Rise in the government funding regarding the malaria diagnostic research and awareness in developing regions will also boost the market during the given time frame. However, low awareness among the people regarding the malaria diagnostics may restrain the growth of the market during the given forecast period.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global malaria diagnostics market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global malaria diagnostics market.
Major industry players profiled as part of the report are Motic, Abbott and Meridian Bioscience, Europe among others.
Rapid Diagnostic Tests (RDTs)
Nucleic Acid Detection
Hospitals and Clinics
Middle East and Africa
Key questions answered by the report
What will be the global malaria diagnostics market size from 2018 to 2023?
How are the major drivers and restraints affecting the global malaria diagnostics market growth and the opportunities which exist for key vendors?
Which segment and region will drive or lead the market growth and why?
A comprehensive analysis of competitive landscape and key market participants’ behaviour
Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth
Intellectual Ventures Laboratory
Access Bio. Inc.
Sysmex Europe GmbH
Meridian Bioscience, Europe
QuantuMDx Group Ltd.
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.